placeholder image
S. J. Hambidge All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Attitudes toward COVID-19 vaccines among pregnant and recently pregnant individuals
    JAMA network open. 2024
  • Coronavirus disease 2019 (COVID-19) vaccination and stillbirth in the Vaccine Safety Datalink
    Obstetrics and Gynecology. 2024
  • Impact of the COVID-19 pandemic on health care utilization in the Vaccine Safety Datalink: retrospective cohort study
    JMIR public health and surveillance. 2024
  • Influenza vaccination accuracy among adults: self-report compared with electronic health record data
    Vaccine. 2024
  • JYNNEOS vaccine safety surveillance in the vaccine safety datalink during the 2022 mpox outbreak in the United States
    Infection. 2024
  • Safety of the seasonal influenza vaccine in 2 successive pregnancies
    JAMA network open. 2024
  • Association between aluminum exposure from vaccines before age 24 months and persistent asthma at age 24 to 59 months
    Academic Pediatrics. 2023
  • COVID-19 booster vaccination in early pregnancy and surveillance for spontaneous abortion
    JAMA network open. 2023
  • COVID-19 vaccine safety surveillance in early pregnancy in the United States: design factors affecting the association between vaccine and spontaneous abortion
    American Journal of Epidemiology. 2023
  • Influenza vaccination among pregnant people before and during the coronavirus disease 2019 (COVID-19) pandemic
    Obstetrics and Gynecology. 2023
  • Influenza vaccination among pregnant women: self-report compared with vaccination data from electronic health records, 2018-2020 influenza seasons
    Public Health Reports. 2023
  • Medically attended acute adverse events in pregnant people after coronavirus disease 2019 (COVID-19) booster vaccination
    Obstetrics and Gynecology. 2023
  • Association of the COVID-19 pandemic with routine childhood vaccination rates and proportion up to date with vaccinations across 8 US health systems in the Vaccine Safety Datalink
    JAMA pediatrics. 2022
  • Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic
    Vaccine. 2022
  • Evaluation of acute adverse events after Covid-19 vaccination during pregnancy
    New England Journal of Medicine. 2022
  • Health care utilization in the 6 months following SARS-CoV-2 infection
    JAMA network open. 2022
  • Kawasaki disease following the 13-valent pneumococcal conjugate vaccine and rotavirus vaccines
    Pediatrics. 2022
  • COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Developing algorithms for identifying major structural birth defects using automated electronic health data
    Pharmacoepidemiology and Drug Safety. 2021
  • Surveillance for adverse events after COVID-19 mRNA vaccination
    JAMA. 2021
  • The childhood vaccination schedule and the lack of association with type 1 diabetes
    Pediatrics. 2021
  • Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination
    Therapeutic advances in drug safety. 2021
  • SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics - eight U.S. health care centers, March 1-May 30, 2020
    MMWR: Morbidity and Mortality Weekly Report. 2020
  • The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: a Vaccine Safety Datalink study
    Pharmacoepidemiology and Drug Safety. 2018
  • Febrile seizure risk after vaccination in children one to five months of age
    Pediatric Neurology. 2017
  • First trimester influenza vaccination and risks for major structural birth defects in offspring
    Journal of Pediatrics. 2017
  • Identifying birth defects in automated data sources in the Vaccine Safety Datalink
    Pharmacoepidemiology and Drug Safety. 2017
  • Maternal Tdap vaccination and risk of infant morbidity
    Vaccine. 2017
  • Maternal and infant outcomes after human papillomavirus vaccination in the periconceptional period or during pregnancy
    Obstetrics and Gynecology. 2017
  • Febrile seizure risk after vaccination in children 6 to 23 months
    Pediatrics. 2016
  • Influenza vaccination during pregnancy: influenza seasons 2002-2012, Vaccine Safety Datalink
    American Journal of Preventive Medicine. 2016
  • Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013
    Vaccine. 2016
  • Risk of anaphylaxis after vaccination in children and adults
    Journal of Allergy and Clinical Immunology. 2016
  • Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations
    JAMA. 2015
  • Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006
    Vaccine. 2015
  • Safety of measles-containing vaccines in 1-year-old children
    Pediatrics. 2015
  • Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy
    Obstetrics and Gynecology. 2015
  • Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes
    JAMA. 2014
  • Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink Sites
    Preventive Medicine. 2014
  • Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine
    Vaccine. 2014
  • Timely versus delayed early childhood vaccination and seizures
    Pediatrics. 2014
  • Vaccinations given during pregnancy, 2002-2009: a descriptive study
    American Journal of Preventive Medicine. 2014
  • A population-based cohort study of undervaccination in 8 managed care organizations across the United States
    JAMA pediatrics. 2013
  • Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age
    JAMA pediatrics. 2013
  • Effect of age on the risk of fever and seizures following immunization with measles-containing vaccines in children
    JAMA pediatrics. 2013
  • Maternal safety of trivalent inactivated influenza vaccine in pregnant women
    Obstetrics and Gynecology. 2013
  • Vaccination site and risk of local reactions in children 1 through 6 years of age
    Pediatrics. 2013
  • Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children
    Pediatrics. 2012
  • Injection site and risk of medically attended local reactions to acellular pertussis vaccine
    Pediatrics. 2011
  • Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink
    Archives of Pediatrics and Adolescent Medicine. 2011
  • Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures
    Pediatrics. 2010
  • Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study
    BMC Infectious Diseases. 2009
  • Predictive value of seizure ICD-9 codes for vaccine safety research
    Vaccine. 2009
  • Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study
    Vaccine. 2009
  • Varicella vaccination and ischemic stroke in children: is there an association?
    Pediatrics. 2009
  • Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children
    Pediatrics. 2008
  • Contact
    full name
  • S. J. Hambidge
  • Quick Info
     
    Collaboration